Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.

Formo is a Berlin-based startup that produces animal-free cheese using micro fermentation of Koji proteins.

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.